首页> 外国专利> ENHANCEMENT OF ANTIBODY-CYTOKINE FUSION PROTEIN MEDIATED IMMUNE RESPONSES BY COMBINED TREATMENT WITH IMMUNOCYTOKINE UPTAKE ENHANCING AGENTS

ENHANCEMENT OF ANTIBODY-CYTOKINE FUSION PROTEIN MEDIATED IMMUNE RESPONSES BY COMBINED TREATMENT WITH IMMUNOCYTOKINE UPTAKE ENHANCING AGENTS

机译:与免疫细胞因子增强剂联合治疗增强抗体细胞因子融合蛋白介导的免疫反应

摘要

Disclosed are compositions for treating tumors and the use of suchcompositions. Disclosed compositions enhance the uptake of immunocytokinesintotumors, and are based on a combination of an immunocytokine with animmunocytokineuptake enhancing agent. The immune uptake enhancing agent is taxol, docetaxel,10-deacetylBaccatin III, cyclophosphamid or carboplatin, and can be administered to amammal prior to the immunokine. Disclosed compositions are particularly usefulforreducing tumor size and metastasis in a mammal.
机译:公开了用于治疗肿瘤的组合物及其用途成分。公开的组合物增强了免疫细胞因子的摄取进入肿瘤,并且是基于免疫细胞因子与免疫细胞因子吸收促进剂。免疫吸收增强剂是紫杉醇,多西紫杉醇,10-脱乙酰基浆果赤霉素III,环磷酰胺或卡铂,可以施用于免疫因子之前的哺乳动物。公开的组合物特别有用对于减少哺乳动物的肿瘤大小和转移。

著录项

  • 公开/公告号CA2412845C

    专利类型

  • 公开/公告日2014-07-22

    原文格式PDF

  • 申请/专利权人 LEXIGEN PHARMACEUTICALS CORP.;

    申请/专利号CA20012412845

  • 申请日2001-06-29

  • 分类号A61K39/395;A61K31/282;A61K31/337;A61K31/675;A61K38/19;A61K38/20;A61P35;C07K16/30;C07K19;

  • 国家 CA

  • 入库时间 2022-08-21 15:54:57

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号